4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-002290
Chief Financial Officer sold 40,000 shares at an average $61.70 ($2,467,941)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2022-01-05 | Sale | −15,908 | $60.50 | $962,434 | 488,097 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2022-01-05 | Sale | −16,528 | $62.00 | $1,024,736 | 471,569 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2022-01-05 | Sale | −3,778 | $63.17 | $238,656 | 467,791 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2022-01-05 | Sale | −3,786 | $63.95 | $242,115 | 464,005 | D |
| Open-market sales · 40,000 sh · avg $61.70 · $2,467,941 | |||||||
Loading xslF345X03/doc4.xml…